State of Wisconsin Investment Board
RVNC

State of Wisconsin Investment Board’s Revance Therapeutics, Inc. RVNC Stock Holding History

State of Wisconsin Investment Board’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-56,767
Closed -$295K – 2392
2024
Q3 		$295K Hold
56,767
– – ﹤0.01% 2053
2024
Q2 		$146K Sell
56,767
-12,305
-18% -$42K ﹤0.01% 2191
2024
Q1 		$340K Sell
69,072
-38,346
-36% -$227K ﹤0.01% 1919
2023
Q4 		$944K Buy
107,418
+29,386
+38% +$241K ﹤0.01% 1408
2023
Q3 		$895K Sell
78,032
-15,146
-16% -$291K ﹤0.01% 1435
2023
Q2 		$2.36M Buy
93,178
+19,962
+27% +$622K 0.01% 1251
2023
Q1 		$2.36M Sell
73,216
-8,098
-10% -$252K 0.01% 1250
2022
Q4 		$1.5M Buy
81,314
+9,771
+14% +$224K ﹤0.01% 1387
2022
Q3 		$1.93M Sell
71,543
-1,408
-2% -$28.6K 0.01% 1351
2022
Q2 		$1.01M Sell
72,951
-15,849
-18% -$244K ﹤0.01% 1627
2022
Q1 		$1.73M Hold
88,800
– – ﹤0.01% 1536
2021
Q4 		$1.45M Hold
88,800
– – ﹤0.01% 1348
2021
Q3 		$2.47M Hold
88,800
– – 0.01% 1234
2021
Q2 		$2.63M Hold
88,800
– – 0.01% 1223
2021
Q1 		$2.48M Sell
88,800
-11,900
-12% -$329K 0.01% 1193
2020
Q4 		$2.85M Sell
100,700
-3,100
-3% -$80.3K 0.01% 1129
2020
Q3 		$2.61M Buy
103,800
+10,100
+11% +$265K 0.01% 1111
2020
Q2 		$2.29M Sell
93,700
-175,345
-65% -$3.46M 0.01% 1097
2020
Q1 		$3.98M Buy
269,045
+21,000
+8% +$434K 0.01% 873
2019
Q4 		$4.03M Buy
248,045
+111,016
+81% +$1.72M 0.01% 995
2019
Q3 		$1.78M Buy
137,029
+10,700
+8% +$131K ﹤0.01% 1039
2019
Q2 		$1.64M Buy
126,329
+55,029
+77% +$694K ﹤0.01% 1049
2019
Q1 		$1.12M Buy
71,300
+10,100
+17% +$175K ﹤0.01% 1132
2018
Q4 		$1.23M Buy
61,200
+400
+0.7% +$8.81K ﹤0.01% 1073
2018
Q3 		$1.51M Buy
60,800
+27,400
+82% +$745K ﹤0.01% 1092
2018
Q2 		$917K Buy
33,400
+15,400
+86% +$463K ﹤0.01% 1195
2018
Q1 		$554K Hold
18,000
– – ﹤0.01% 1276
2017
Q4 		$643K Hold
18,000
– – ﹤0.01% 1241
2017
Q3 		$496K Hold
18,000
– – ﹤0.01% 1298
2017
Q2 		$475K Buy
+18,000
New +$401K ﹤0.01% 1295

Other funds holding RVNC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

State of Wisconsin Investment Board's RVNC Position: Q4 2024 in Review

State of Wisconsin Investment Board sold out of Revance Therapeutics, Inc. (RVNC) in Q4 2024, closing a stake of 56,767 shares — an estimated $295K sold.

State of Wisconsin Investment Board first reported a position in RVNC in Q2 2017 and held it in 30 quarters. The position peaked at $4.03M in Q4 2019. 173 funds tracked by Wall St. Rank hold RVNC as of Q4 2024.

  • State of Wisconsin Investment Board reported no remaining Revance Therapeutics, Inc. position as of Q4 2024 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 56,767 Revance Therapeutics, Inc. shares in Q4 2024, an estimated $295K.
  • State of Wisconsin Investment Board first reported a position in Revance Therapeutics, Inc. in Q2 2017 and held it in 30 quarters.
  • State of Wisconsin Investment Board's Revance Therapeutics, Inc. position peaked at $4.03M in Q4 2019.
  • 173 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q4 2024.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2024, filed 14 Feb 2025.